Harvard Bioscience, Inc. Invites You to Join Its Second Quarter 2001 Conference Call on the Web
HOLLISTON, Mass., July 25 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce results for the second quarter of 2001 after the market closes on Tuesday, July 31, 2001.
At 6:00 p.m. Eastern Time on July 31, 2001, management will host a conference call to discuss the Company's quarterly results, along with business highlights and outlook. In addition, management may answer questions concerning business and financial developments and trends, the Company's view on earnings forecasts, and other business and financial matters affecting the Company. Some responses to questions may contain information that has not previously been disclosed.
The conference call will be simultaneously broadcast over the Internet and can be accessed through the Harvard Bioscience, Inc. web site. To listen to the conference call, log on to the web at: www.harvardbioscience.com, click on the investor relations button and then click on the web cast icon. If you are unable to listen to the live web cast the call will be archived for two weeks on our web site. The live conference call can also be accessed in a "listen only" mode by dialing 877-313-7707.
Harvard Bioscience is a global developer, manufacturer and marketer of innovative, enabling tools in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. We sell approximately 10,000 products to thousands of researchers in over 60 countries though our 1,000 page catalog, and through our distributors, the most notable of which is AP Biotech. We have sales and manufacturing operations in the United States, the United Kingdom, and Germany and sales offices in France and Canada.
For investor inquiries, please call (508) 893-8066. Press releases may be found on our web site, http://www.harvardbioscience.com.
SOURCE Harvard Bioscience, Inc.
CONTACT: Jim Warren, CFO, jwarren@harvardbioscience.com, or David Green, President, dgreen@harvardbioscience.com, or Chane Graziano, CEO, cgraziano@harvardbioscience.com, all of Harvard Bioscience, Inc./
Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.